DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine

Information source: TC Erciyes University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Drug-induced Ototoxicity in Peritoneal Dialysis Patients

Intervention: N-acetylcysteine (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: TC Erciyes University

Official(s) and/or principal investigator(s):
Bulent Tokgoz, MD, Principal Investigator, Affiliation: Erciyes University School of Medicine

Summary

The purpose of this study is to determine whether N-acetylcysteine is effective in the prevention of hearing loss in both ears due to aminoglycoside and/or vancomycine induced ototoxicity in peritoneal dialysis patients.

Clinical Details

Official title: The Evaluation of the Protective Effect of N-Acetylcysteine Against Drug Induced Ototoxicity in Peritoneal Dialysis Patients

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Eligibility

Minimum age: 18 Years. Maximum age: 70 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- End-stage renal disease

- Undergoing continuous ambulatory peritoneal dialysis as a renal replacement therapy

- Clinical diagnosis of a peritonitis episode in a continuous ambulatory peritoneal

dialysis patient

- Developing the first continuous ambulatory peritoneal dialysis related peritonitis

episode Exclusion Criteria:

- Being treated with aminoglycoside antibiotics and vancomycine within the previous 3

months

- Detection of mechanical occlusion of external ear

- Having signs of disturbed integrity of tympanic membrane on otoscopy or tympanometry

- History of a continuous ambulatory peritoneal dialysis related peritonitis

Locations and Contacts

Erciyes University School of Medicine Department of Nephrology, Kayseri 38039, Turkey
Additional Information

Starting date: February 2008
Last updated: May 26, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017